Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6- to 11-Year-Olds with Cystic Fibrosis: An Observational Study.

Saved in:
Bibliographic Details
Title: Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6- to 11-Year-Olds with Cystic Fibrosis: An Observational Study.
Authors: Pittman JE; Department of Pediatrics, School of Medicine, Washington University, St. Louis, Missouri., Morgan S; Department of Microbiology, and., McCreary M; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center and., Vu PT; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center and., Jorth P; Department of Pathology and Laboratory Medicine.; Department of Medicine, and.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California., Heltshe S; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center and.; Center for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington., Hoffman LR; Department of Microbiology, and.; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.; Center for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington., Kelly A; Division of Endocrinology and Diabetes, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Sagel SD; Department of Pediatrics, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Singh PK; Department of Microbiology, and., Solomon GM; Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Rosenfeld M; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.; Center for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington., Ratjen F; Division of Respiratory Medicine, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.; Translational Medicine, SickKids Research Institute, Toronto, Ontario, Canada; and.; University of Toronto, Toronto, Ontario, Canada.
Corporate Authors: PROMISE Pediatric substudy Investigators
Source: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2025 Nov; Vol. 22 (11), pp. 1696-1708.
Publication Type: Journal Article; Observational Study; Multicenter Study
Journal Info: Publisher: American Thoracic Society Country of Publication: England NLM ID: 101600811 Publication Model: Print Cited Medium: Internet ISSN: 2325-6621 (Electronic) Linking ISSN: 23256621 NLM ISO Abbreviation: Ann Am Thorac Soc Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2325-6621
DOI:10.1513/AnnalsATS.202501-103OC